(ATRA) Atara Biotherapeutics complete technical analysis [charts+indicators] | Buy/Sell Atara Biotherapeutics | (ATRA) share price targets
Complete technical analysis of Atara Biotherapeutics (ATRA) by charts plus indicators, forecast predictions and share price targets for Atara Biotherapeutics (ATRA)
Atara Biotherapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-23 View latest technical analysis
10 day averaged volume of Atara Biotherapeutics is 119820
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Mon Sep 2024 | 7.36 | 7.87 | 7.95 | 7.35 | 1.092 times |
| 20 Fri Sep 2024 | 7.79 | 8.00 | 8.11 | 7.60 | 1.015 times |
| 19 Thu Sep 2024 | 7.93 | 8.08 | 8.34 | 7.77 | 1.012 times |
| 18 Wed Sep 2024 | 7.87 | 8.55 | 8.80 | 7.85 | 1.006 times |
| 17 Tue Sep 2024 | 8.51 | 8.77 | 9.12 | 8.51 | 0.366 times |
| 16 Mon Sep 2024 | 8.60 | 9.13 | 9.49 | 8.60 | 1.113 times |
| 13 Fri Sep 2024 | 9.72 | 8.11 | 9.81 | 8.11 | 1.632 times |
| 12 Thu Sep 2024 | 8.08 | 8.40 | 8.50 | 8.02 | 0.674 times |
| 11 Wed Sep 2024 | 8.31 | 8.60 | 8.85 | 8.03 | 1.052 times |
| 10 Tue Sep 2024 | 8.59 | 8.95 | 9.33 | 8.57 | 0.603 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 7.2 as stoploss in an intra day buy trade for a target of 8.15. However, stock will show a bearish move below 7.2.
Share price targets for Atara Biotherapeutics (ATRA)
| Target Type | Value |
| Downside Target | 0.37 |
| Downside Target | 0.48 |
| Downside Target | 0.76 |
| Downside Target | 6.50 |
| Downside Target | 6.81 |
| Downside Target | 7.13 |
| Downside Target | 7.31 |
| Upside Target | 7.60 |
| Upside Target | 7.95 |
| Upside Target | 9.49 |
| Upside Target | 10.00 |
| Upside Target | 10.21 |
| Upside Target | 10.40 |
| Upside Target | 10.69 |
| Upside Target | 12.98 |
Intraday share price targets for Atara Biotherapeutics (ATRA)
| Target Type | Value |
| Downside Intraday Target | 7.16 |
| Downside Intraday Target | 6.95 |
| Upside Intraday Target | 7.76 |
| Upside Intraday Target | 8.15 |
| Upside Intraday Target | 7.55 |
Weekly technical analysis of Atara Biotherapeutics (ATRA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Mon Sep 2024 | 7.36 | 7.87 | 7.95 | 7.35 | 0.242 times |
| 20 Fri Sep 2024 | 7.79 | 9.13 | 9.49 | 7.60 | 0.822 times |
| 13 Fri Sep 2024 | 9.72 | 10.05 | 10.21 | 8.02 | 0.224 times |
| 06 Fri Sep 2024 | 9.47 | 7.50 | 10.69 | 6.81 | 37.33 times |
| 30 Fri Aug 2024 | 7.60 | 7.13 | 7.67 | 7.13 | 0.284 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Atara Biotherapeutics (ATRA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Mon Sep 2024 | 7.36 | 7.50 | 10.69 | 6.81 | 3.071 times |
| 30 Fri Aug 2024 | 7.60 | 10.06 | 10.40 | 6.50 | 0.945 times |
| 31 Wed Jul 2024 | 9.83 | 8.50 | 12.98 | 7.31 | 0.068 times |
| 28 Fri Jun 2024 | 8.50 | 0.56 | 10.00 | 0.37 | 0.731 times |
Scroll below to view daily charts
Price has moved down this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Atara Biotherapeutics (ATRA)
Price action analysis of Atara Biotherapeutics ( (ATRA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Atara Biotherapeutics ( (ATRA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Atara Biotherapeutics ( (ATRA) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Atara Biotherapeutics ( (ATRA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Atara Biotherapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Atara Biotherapeutics in short term but the sell signal is initial and weak.
Atara Biotherapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Atara Biotherapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Atara Biotherapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.34 and Atara Biotherapeutics (ATRA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Atara Biotherapeutics (ATRA) stock. Volume based technical analysis of Atara Biotherapeutics (ATRA) stock is negative.
Atara Biotherapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Atara Biotherapeutics ( (ATRA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Atara Biotherapeutics ( (ATRA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Atara Biotherapeutics ( (ATRA) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Atara Biotherapeutics ( (ATRA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Atara Biotherapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Atara Biotherapeutics in short term but the sell signal is initial and weak.
Atara Biotherapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Atara Biotherapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Atara Biotherapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.34 and Atara Biotherapeutics (ATRA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Atara Biotherapeutics (ATRA) stock. Volume based technical analysis of Atara Biotherapeutics (ATRA) stock is negative.
Atara Biotherapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.